242
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy

ORCID Icon, ORCID Icon &
Pages 1311-1322 | Published online: 03 Jun 2022

References

  • Milne RJ, Beasley R. Hospital admissions for chronic obstructive pulmonary disease. NZ Med J. 2015;128(1408):23–35.
  • Barnard L, Zhang J. The impact of respiratory disease in New Zealand: 2016 update; 2016 [ cited October 7, 2021]. Available from: https://www.asthmafoundation.org.nz/research/the-impact-of-respiratory-disease-in-New-Zealand-2016-update. Accessed March 28, 2022.
  • Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185–2196. doi:10.1056/NEJMoa1503326
  • Ni YN, Luo J, Yu H, Liu D, Liang BM, Liang ZA. The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis. Am J Emerg Med. 2018;36(2):226–233. doi:10.1016/j.ajem.2017.07.083
  • Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329–2330. doi:10.1001/jama.2020.6825
  • Sun J, Li Y, Ling B, et al. High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study. Int J Chron Obstruct Pulmon Dis. 2019;14:1229–1237. doi:10.2147/COPD.S206567
  • Nagata K, Kikuchi T, Horie T, et al. Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease. A multicenter randomized crossover trial. Ann Am Thorac Soc. 2018;15(4):432–439. doi:10.1513/AnnalsATS.201706-425OC
  • McKinstry S, Pilcher J, Bardsley G, et al. Nasal high flow therapy and PtCO2 in stable COPD: a randomized controlled cross-over trial. Respirology. 2018;23(4):378–384. doi:10.1111/resp.13185
  • Fraser JF, Spooner AJ, Dunster KR, Anstey CM, Corley A. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016;71(8):759–761. doi:10.1136/thoraxjnl-2015-207962
  • Pisani L, Fasano L, Corcione N, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax. 2017;72(4):373–375. doi:10.1136/thoraxjnl-2016-209673
  • Milne RJ, Hockey H, Rea H. Long-term air humidification therapy is cost effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis. Value Health. 2014;17(4):320–327. doi:10.1016/j.jval.2014.01.007
  • Rea H, McAuley S, Jayaram L, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010;104(4):525–533. doi:10.1016/j.rmed.2009.12.016
  • Good WR, Garrett J, Hockey HUP, Jayaram L, Wong C, Rea H. The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis. ERJ Open Res. 2021;7:1. doi:10.1183/23120541.00711-2020
  • Sorensen SS, Storgaard LH, Weinreich UM. Cost-effectiveness of domiciliary high flow nasal cannula treatment in COPD patients with chronic respiratory failure. ClinicoEcon. 2021;13:553–564.
  • Storgaard LH, Hockey HU, Laursen BS, Weinreich UM. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018;13:1195–1205. doi:10.2147/COPD.S159666
  • Asthma-Respiratory-Foundation-NZ. NZ COPD Guidelines 2021. Wellington, New Zealand; 2021 [ cited September, 2021]. Available from: https://www.nzrespiratoryguidelines.co.nz/uploads/8/3/0/1/83014052/nz_copd_guidelines_web.pdf. Accessed March 28, 2022.
  • Augusti A, Beasley R, Celli B; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnoses, management, and prevention of COPD; [ cited October 2021]. Available from: http://www.goldcopd.org. Accessed March 28, 2022.
  • Biselli PJ, Kirkness JP, Grote L, et al. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study. J Appl Physiol. 2017;122(1):82–88. doi:10.1152/japplphysiol.00279.2016
  • Nilius G, Franke KJ, Domanski U, Ruhle KH, Kirkness JP, Schneider H. Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol. 2013;755:27–34.
  • Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis. 2008;5(2):81–86.
  • Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527